{
    "clinical_study": {
        "@rank": "164845", 
        "arm_group": [
            {
                "arm_group_label": "HX106 590mg", 
                "arm_group_type": "Experimental", 
                "description": "HX106 590mg/day"
            }, 
            {
                "arm_group_label": "HX106 1180mg", 
                "arm_group_type": "Experimental", 
                "description": "HX106 1180mg/day"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo"
            }
        ], 
        "brief_summary": {
            "textblock": "The objectives of the current study are to evaluate the efficacy and safety of HX106 in\n      healthy adults with subjective memory complaints for improving neurocognitive functions and\n      to find the changes of brain using magnetic resonance imaging and their associations with\n      the neurocognitive function enhancement."
        }, 
        "brief_title": "Effects of HX106 on Improvement in Cognitive-Bio-Markers of Memory Function", 
        "condition": "Healthy Adults With Subjective Memory Complaints", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age between 20 and 60 years old,\n\n          -  Global Deterioration Scale score (GDS) of 2\n\n          -  One or more symptoms of subjective memory impairment\n\n          -  High school or higher levels of education.\n\n        Exclusion Criteria:\n\n          -  Current pregnancy or breast-feeding\n\n          -  Evidence of neurologic or medical conditions\n\n          -  Axis I diagnosis when assessed by the board certified psychiatrist using the\n             Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental\n             Disorder, 4th edition (DSM-IV)(SCID-IV),\n\n          -  One or more major depressive episode during last 12 months\n\n          -  Mini-mental status examination score of 24 or less\n\n          -  Clinical Dementia Rating score of 0.5 or more suggesting cognitive impairment beyond\n             self-perceived subjective deficits\n\n          -  Intelligence quotient less than 80\n\n          -  Any history of head trauma involving loss of consciousness or seizure\n\n          -  Contraindications to magnetic resonance imaging (MRI)\n\n          -  Use of psychotropics in last 3 months\n\n          -  Use of oral contraceptive medication\n\n          -  Participation in other clinical trials during the study period that might affect the\n             outcome of the present study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "60 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "75", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 26, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01956097", 
            "org_study_id": "HX106"
        }, 
        "intervention": [
            {
                "arm_group_label": "HX106 590mg", 
                "intervention_name": "HX106 590mg", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "HX106 1180mg", 
                "intervention_name": "HX106 1180mg", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "October 1, 2013", 
        "location": {
            "contact": {
                "email": "alexhsjeong@gmail.com", 
                "last_name": "Hyeonseok S Jeong, MS", 
                "phone": "82-2-3277-6929"
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "120-750"
                }, 
                "name": "Ewha W. University"
            }, 
            "investigator": {
                "last_name": "In Kyoon Lyoo, MD, PhD, MMS", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "3", 
        "official_title": "Effects of HX106 on Improvement in Cognitive-Bio-Markers of Memory Function in Healthy Adults With Subjective Memory Complaints: An 8-Week Prospective Randomized Double-Blind Placebo-Controlled Trial With Multimodal Neuroimaging and Neurocognitive Assessments", 
        "overall_contact": {
            "email": "kjieun@ewha.ac.kr", 
            "last_name": "Jieun E Kim, MD, PhD", 
            "phone": "82-2-3277-6932"
        }, 
        "overall_official": {
            "affiliation": "Ewha W. University", 
            "last_name": "In Kyoon Lyoo, MD, PhD, MMS", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Korea: Ministry of Food and Drug Safety", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Changes from baseline in neurocognitive function", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 8th weeks"
            }, 
            {
                "description": "Morphometric analysis of brain structures in magnetic resonance imaging", 
                "measure": "Changes from baseline in brain structure analyzed using the computational approach", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 8th weeks"
            }, 
            {
                "description": "Blood oxygenation level dependent (BOLD) signal intensity and their connectivity assessed using functional magnetic resonance imaging scans", 
                "measure": "Changes from baseline in brain function analyzed using the computational approach", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 8th weeks"
            }, 
            {
                "description": "Brain metabolite concentrations assessed using magnetic resonance spectroscopy", 
                "measure": "Changes from baseline in brain biochemical metabolism analyzed using the computational approach", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 8th weeks"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01956097"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Ewha Womans University", 
            "investigator_full_name": "In Kyoon Lyoo", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change from baseline in Subjective Memory Complaints Questionnaire scores at 8th weeks", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 8th weeks"
            }, 
            {
                "measure": "Number of participants with adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "1st week"
            }, 
            {
                "measure": "Number of participants with adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "4th weeks"
            }, 
            {
                "measure": "Number of participants with adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "8th weeks"
            }
        ], 
        "source": "Ewha Womans University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ewha Womans University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}